Abstract
Traumatic brain injury (TBI) elicits a sustained neuroinflammatory cascade that contributes to neuronal loss and poor functional recovery. Topiramate (TPM) is an FDA-approved antiepileptic drug with anti-excitotoxic and anti-inflammatory actions. Here, we tested whether TPM mitigates neuroinflammation and improves outcomes in experimental TBI models. Adult mice subjected to controlled cortical impact (CCI) received TPM (80 mg/kg, i.p.) 30 min post-injury and every 12 h for 48 h. Outcomes included neuronal survival, brain water content, neurological function, lipid peroxidation, inflammatory cytokines expression, astrocyte and microglia activation. The potential underlying mechanism was determined by measuring microglial polarization markers and neuronal Sirt1 expression. A traumatic neuronal injury (TNI) model in primary cortical neurons assessed dose (10–100 µM TPM) and therapeutic window (0–4 h post-injury). The Sirt1 inhibitor sirtinol was used in vivo and in vitro to probe mechanism. The results showed that TPM reduced neuronal loss, ipsilateral brain water content, and cleaved caspase-3, and improved mNSS and beam-walk performance on days 7 and 14. TPM decreased levels of MDA, 4-HNE, TNF-α, IL-1β, and IL-6 while increasing IL-10 expression, and suppressed GFAP⁺ astrocytosis and Iba-1⁺ microgliosis. Notably, TPM shifted microglial phenotype toward an M2-like state and enhanced nuclear Sirt1 expression in neurons. Sirtinol attenuated TPM-induced protection and partly reversed the TPM-induced changes in microglial polarization markers. In vitro, TPM (50–100 µM) reduced LDH release, preserved calcein signal, and inhibited lipid peroxidation, with efficacy observed when administered within 2 h post-injury, which were blunted by sirtinol. In summary, these data indicate that TPM confers neuroprotection after TBI, at least in part, by engaging Sirt1 and promoting a pro-resolving microglial phenotype, supporting its therapeutic potential for the treatment of TBI.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Anand, K. V., Shahid, P. T. & Shameel, K. K. Evaluating GCS and FOUR Score in predicting mortality of traumatic brain injury patients (TBI): A prospective study in a tertiary hospital of South Malabar. J. Pharm. Bioallied Sci. 16, S598–S600. https://doi.org/10.4103/jpbs.jpbs_884_23 (2024).
Chen, T. et al. Whole body vibration attenuates brain damage and neuroinflammation following experimental traumatic brain injury. Front. Cell Dev. Biol. 10, 847859. https://doi.org/10.3389/fcell.2022.847859 (2022).
Kolias, A. G., Rubiano, A. M., Figaji, A., Servadei, F. & Hutchinson, P. J. Traumatic brain injury: Global collaboration for a global challenge. Lancet Neurol. 18, 136–137. https://doi.org/10.1016/S1474-4422(18)30494-0 (2019).
Loane, D. J. & Faden, A. I. Neuroprotection for traumatic brain injury: Translational challenges and emerging therapeutic strategies. Trends Pharmacol. Sci. 31, 596–604. https://doi.org/10.1016/j.tips.2010.09.005 (2010).
Simon, D. W. et al. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat. Rev. Neurol. 13, 572. https://doi.org/10.1038/nrneurol.2017.116 (2017).
Zhang, X. H. et al. Electroacupuncture regulates microglial polarization via inhibiting NF-κB/COX2 pathway following traumatic brain injury. Brain Res. 1818, 148516. https://doi.org/10.1016/j.brainres.2023.148516 (2023).
Witcher, K. G., Eiferman, D. S. & Godbout, J. P. Priming the inflammatory pump of the CNS after traumatic brain injury. Trends Neurosci. 38, 609–620. https://doi.org/10.1016/j.tins.2015.08.002 (2015).
Candelario-Jalil, E., Dijkhuizen, R. M. & Magnus, T. Neuroinflammation, stroke, Blood-brain barrier dysfunction, and imaging modalities. Stroke 53, 1473–1486. https://doi.org/10.1161/STROKEAHA.122.036946 (2022).
Zhang, B. et al. Targeting MAPK pathways by Naringenin modulates microglia M1/M2 polarization in Lipopolysaccharide-stimulated cultures. Front. Cell. Neurosci. 12, 531. https://doi.org/10.3389/fncel.2018.00531 (2018).
Minter, M. R., Taylor, J. M. & Crack, P. J. The contribution of neuroinflammation to amyloid toxicity in Alzheimer’s disease. J. Neurochem. 136, 457–474. https://doi.org/10.1111/jnc.13411 (2016).
Xie, L. et al. Electroacupuncture improves M2 microglia polarization and glia anti-inflammation of hippocampus in Alzheimer’s disease. Front. Neurosci. 15, 689629. https://doi.org/10.3389/fnins.2021.689629 (2021).
Tian, Y. et al. Topiramate attenuates early brain injury following subarachnoid haemorrhage in rats via duplex protection against inflammation and neuronal cell death. Brain Res. 1622, 174–185. https://doi.org/10.1016/j.brainres.2015.06.007 (2015).
Demirci, S. et al. Effects of selenium and topiramate on cytosolic Ca(2+) influx and oxidative stress in neuronal PC12 cells. Neurochem Res. 38, 90–97. https://doi.org/10.1007/s11064-012-0893-z (2013).
Kutluhan, S., Naziroglu, M., Celik, O. & Yilmaz, M. Effects of selenium and Topiramate on lipid peroxidation and antioxidant vitamin levels in blood of Pentylentetrazol-induced epileptic rats. Biol. Trace Elem. Res. 129, 181–189. https://doi.org/10.1007/s12011-008-8287-4 (2009).
Jafari, A., Ghasemnejad-Berenji, H., Nemati, M. & Ghasemnejad-Berenji, M. Topiramate: A novel protective agent against ischemia reperfusion-induced oxidative injury after testicular torsion/detorsion. Am. J. Emerg. Med. 44, 257–261. https://doi.org/10.1016/j.ajem.2020.03.060 (2021).
Mao, X. et al. Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis. Neurochem. Int. 60, 39–46. https://doi.org/10.1016/j.neuint.2011.10.015 (2012).
Auteri, M., Zizzo, M. G. & Serio, R. GABA and GABA receptors in the gastrointestinal tract: From motility to inflammation. Pharmacol. Res. 93, 11–21. https://doi.org/10.1016/j.phrs.2014.12.001 (2015).
Motaghinejad, M., Motevalian, M., Fatima, S., Beiranvand, T. & Mozaffari, S. Topiramate via NMDA, AMPA/kainate, GABA(A) and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats. J. Neural Transm (Vienna). 124, 1369–1387. https://doi.org/10.1007/s00702-017-1771-2 (2017).
Kurul, S. H. et al. Protective effects of topiramate against hyperoxic brain injury in the developing brain. Neuropediatrics 40, 22–27. https://doi.org/10.1055/s-0029-1224101 (2009).
Chen, T. et al. Edonerpic maleate regulates glutamate receptors through CRMP2- and Arc-mediated mechanisms in response to brain trauma. Cell Death Discov. 8, 95. https://doi.org/10.1038/s41420-022-00901-0 (2022).
Pearl, N. Z. et al. Narrative review of topiramate: Clinical uses and pharmacological considerations. Adv. Ther. 40, 3626–3638. https://doi.org/10.1007/s12325-023-02586-y (2023).
Attia, M. A. et al. Topiramate affords neuroprotection in diabetic neuropathy model via downregulating spinal GFAP/inflammatory burden and improving neurofilament production. Toxicol. Mech. Methods 33, 563–577. https://doi.org/10.1080/15376516.2023.2196687 (2023).
Kudin, A. P., Debska-Vielhaber, G., Vielhaber, S., Elger, C. E. & Kunz, W. S. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45, 1478–1487. https://doi.org/10.1111/j.0013-9580.2004.13504.x (2004).
Yang, Y., Li, Q. & Shuaib, A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 39, 881–888. https://doi.org/10.1016/s0028-3908(99)00248-8 (2000).
Liu, X. et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes. Exp. Neurol. 341, 113700. https://doi.org/10.1016/j.expneurol.2021.113700 (2021).
Zhang, J., Gu, Y., Sun, W., Yu, L. & Li, T. Tetrahydrocurcumin protects against GSK3β/PTEN/PI3K/Akt-mediated neuroinflammatory responses and microglial polarization following traumatic brain injury. Mol. Neurobiol. 61, 7026–7036. https://doi.org/10.1007/s12035-024-04034-6 (2024).
Loscher, W. & Trinka, E. The potential of intravenous topiramate for the treatment of status epilepticus. Epilepsy Behav. 138, 109032. https://doi.org/10.1016/j.yebeh.2022.109032 (2023).
Kouzounias, K. et al. Topiramate promotes neurological recovery in a new model of traumatic brain injury in rats. Neuroscience 183, 171–177. https://doi.org/10.1016/j.neuroscience.2011.03.069 (2011).
Narin, F., Hanalioglu, S., Ustun, H., Kilinc, K. & Bilginer, B. Topiramate as a neuroprotective agent in a rat model of spinal cord injury. Neural Regen. Res. 12, 2071–2076. https://doi.org/10.4103/1673-5374.221164 (2017).
Manhapra, A., Chakraborty, A. & Arias, A. J. Topiramate pharmacotherapy for alcohol use disorder and other addictions: A narrative review. J. Addict. Med. 13, 7–22. https://doi.org/10.1097/ADM.0000000000000443 (2019).
Salasky, V. R. & Chang, W. W. Neurotrauma update. Emerg. Med. Clin. North Am. 41, 19–33. https://doi.org/10.1016/j.emc.2022.09.014 (2023).
van Erp, I. A. M. et al. Tackling neuroinflammation after traumatic brain injury: Complement inhibition as a therapy for secondary injury. Neurotherapeutics 20, 284–303. https://doi.org/10.1007/s13311-022-01306-8 (2023).
Yang, X., Xu, S., Qian, Y. & Xiao, Q. Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury. Brain Behav. Immun. 64, 162–172. https://doi.org/10.1016/j.bbi.2017.03.003 (2017).
Xue, Y., Zhang, Y., Wu, Y. & Zhao, T. Activation of GPER-1 attenuates traumatic brain injury-induced neurological impairments in mice. Mol. Neurobiol. 61, 5614–5627. https://doi.org/10.1007/s12035-024-03919-w (2024).
Devanney, N. A., Stewart, A. N. & Gensel, J. C. Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma. Exp. Neurol. 329, 113310. https://doi.org/10.1016/j.expneurol.2020.113310 (2020).
Chan, T. Y. H., Ma, B. Y., Hung, T. K., Wong, J. S. Y. & Lo, B. W. Y. Microglial polarization and therapeutic strategies in post-stroke neuroinflammation. Neurol. Ther. https://doi.org/10.1007/s40120-025-00825-8 (2025).
Li, Y. F., Ren, X., Zhang, L., Wang, Y. H. & Chen, T. Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals. Front. Aging Neurosci. 14, 901117. https://doi.org/10.3389/fnagi.2022.901117 (2022).
Nathalie, M. et al. Targeting microglial polarization to improve TBI outcomes. CNS Neurol. Disord. Drug Targets 20, 216–227. https://doi.org/10.2174/1871527319666200918145903 (2021).
Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800. https://doi.org/10.1038/35001622 (2000).
Yeung, F. et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369–2380. https://doi.org/10.1038/sj.emboj.7600244 (2004).
Jeong, H. et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 18, 159–165. https://doi.org/10.1038/nm.2559 (2011).
Price, N. L. et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15, 675–690. https://doi.org/10.1016/j.cmet.2012.04.003 (2012).
Chen, X. et al. Omega-3 polyunsaturated fatty acid attenuates traumatic brain injury-induced neuronal apoptosis by inducing autophagy through the upregulation of SIRT1-mediated deacetylation of Beclin-1. J. Neuroinflammation 15, 310. https://doi.org/10.1186/s12974-018-1345-8 (2018).
Chen, X. et al. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury. J. Neuroinflammation 15(1), 116. https://doi.org/10.1186/s12974-018-1151-3 (2018).
Wang, D. et al. Propofol alleviates traumatic brain injury through regulating Th17/Treg balance by activation of the AMPK/SIRT1 pathway. Toxicol. Mech. Methods 35, 644–654. https://doi.org/10.1080/15376516.2025.2481893 (2025).
Funding
This work was supported by the Basic Research Project of Wuxi Science and Technology Bureau (No. K20231051), the top talent support program for young and middle-aged people of Wuxi health committee (BJ2023111).
Author information
Authors and Affiliations
Contributions
Conceptualization was done by T. C. and Y. H. W.; investigation was done by X. Z., A. L., and Y. Z.; data collection and organization were conducted by W. K. W. and Z. Z. Y.; original draft was written by X. Z.; review and editing were performed by T. C. and Y. H. W.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhang, X., Li, A., Zhang, Y. et al. Topiramate protects against neuroinflammation in response to traumatic brain injury via activating Sirt1 signaling. Sci Rep (2026). https://doi.org/10.1038/s41598-026-45079-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-45079-y
